Search

Your search keyword '"Osawa, Takahiro"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Osawa, Takahiro" Remove constraint Author: "Osawa, Takahiro" Database Unpaywall Remove constraint Database: Unpaywall
225 results on '"Osawa, Takahiro"'

Search Results

3. MP01-03 CURRENT TREATMENT PATTERNS AND OUTCOMES OF 109 PATIENTS WITH SEX CORD STROMAL TUMORS IN JAPAN: A MULTI-INSTITUTIONAL STUDY

4. A prospective study of surgeons’ workloads and associated factors in real-world practice

5. Physiotherapy for continence and muscle function in prostatectomy: a randomised controlled trial

6. Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project

15. Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study

16. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy

17. Multi-Sensor Satellite to Assess Sea Level Rise and Land Subsidence Impact on the Flood Crisis on the East Coast of North Sumatra and Medan City, Indonesia

21. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment

26. Sexual function using the EORTC QLQ‐TC26 in testicular cancer survivors: A multi‐institutional, cross‐sectional study

27. Impact of postoperative complications on long-term survival in bladder cancer patients

28. Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study

29. Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial

30. Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care)

31. Clinical Practice Guidelines for tuberous sclerosis complex‐associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update

32. Real‐world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST‐NIVO study): 36‐month follow‐up results of a clinical chart review

35. Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers

36. MP22-17 THE BODY IMAGE SCALE (BIS) CAN IDENTIFY SYMPTOMS RELATED TO BODY IMAGE AFTER BLADDER CANCER TREATMENT: VALIDATION OF THE JAPANESE VERSION OF THE BIS

37. MP48-20 MENTAL WORKLOADS OF SURGEONS IN UROLOGY: A PROSPECTIVE OBSERVATIONAL STUDY

38. The comprehensive analysis of relationship between gut microbiome and treatment outcome of androgen deprivation therapy (ADT)-based treatment in patients with metastatic castration-sensitive and -resistant prostate cancer.

39. Cross-sectional study of patients' (pts) and physicians' needs and the financial toxicity of systemic treatment for metastatic renal cell carcinoma (mRCC) in Japan.

40. Evaluation of the safety and effectiveness of cryoablation in the treatment of renal angiomyolipoma related to tuberous sclerosis complex: The Cryo-TSC.

42. Prognostic value of immune phenotype and PD-L1 status in recurrent or metastatic renal cell carcinoma: an exploratory analysis of the ARCHERY study

44. Development and validation of a measurement system for laparoscopic surgical procedures in practical surgery training

45. Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma

46. Fatal case of subdural empyema caused by Campylobacter rectus and Slackia exigua

49. Validation of the Japanese version of the Body Image Scale for bladder cancer patients

50. IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation

Catalog

Books, media, physical & digital resources